Calreticulin is an upstream regulator of calcineurin

Biochemical and Biophysical Research Communications

Volumn 311, Issue 4, 2003, Pages 1173-1179

  Lynch, Jeffrey ^a   Michalak, Marek ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Calcineurin; Calcium homeostasis; Calreticulin; Cardiac development; Endoplasmic reticulum

Indexed keywords

BUFFER; CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM BINDING PROTEIN; CALCIUM ION; CALRETICULIN; CHAPERONE; PROTEIN KINASE (CALCIUM,CALMODULIN); TACROLIMUS;

CALCIUM SIGNALING; CALCIUM TRANSPORT; CONGENITAL HEART MALFORMATION; CORRELATION ANALYSIS; EMBRYO DEATH; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; LETHALITY; MOLECULAR DYNAMICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION;

ANIMALIA;

EID: 0242437811     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.040     Document Type: Article

References (52)

1. Berridge M.J. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium. 32:2002;235-249.
2. 2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium. 32:2002;269-278.
3. Ma J., Pan Z. Retrograde activation of store-operated calcium channel. Cell Calcium. 33:2003;375-384.
4. 2+-handling proteins. J. Cell Biol. 160:2003;475-479.
5. 2+ store: a view from the lumen. Trends Biochem. Sci. 23:1998;10-14.
6. Corbett E.F., Michalak M. Calcium, a signaling molecule in the endoplasmic reticulum? Trends Biochem. Sci. 25:2000;307-311.
7. Molinari M., Helenius A. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science. 288:2000;331-333.
8. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem. J. 344:1999;281-292.
9. Nakamura K., Zuppini A., Arnaudeau S., Lynch J., Ahsan I., Krause R., Papp S., De Smedt H., Parys J.B., Müller-Esterl W., Lew D.P., Krause K.-H., Demaurex N., Opas M., Michalak M. Functional specialization of calreticulin domains. J. Cell Biol. 154:2001;961-972.
10. Mesaeli N., Nakamura K., Zvaritch E., Dickie P., Dziak E., Krause K.-H., Opas M., MacLennan D.H., Michalak M. Calreticulin is essential for cardiac development. J. Cell Biol. 144:1999;857-868.
11. 2+ waves. Cell. 82:1995;765-771.
12. Fasolato C., Pizzo P., Pozzan T. Delayed activation of the store-operated calcium current induced by calreticulin overexpression in RBL-1 cells. Mol. Biol. Cell. 9:1998;1513-1522.
13. 2+ stores and reveals aspects of their lumenal microenvironment and function. J. Cell Biol. 130:1995;847-855.
14. 2+ influx. J. Biol. Chem. 271:1996;9332-9339.
15. 2+ store depletion. J. Biol. Chem. 275:2000;36676-36682.
16. Arnaudeau S., Frieden M., Nakamura K., Castelbou C., Michalak M., Demaurex N. Calreticulin differentially modulates calcium uptake and release in the endoplasmic reticulum and mitochondria. J. Biol. Chem. 277:2002;46696-46705.
17. Mesaeli N., Nakamura K., Opas M., Michalak M. Endoplasmic reticulum in the heart, a forgotten organelle? Mol. Cell. Biochem. 224:2001;1-6.
18. Knee R., Ahsan I., Mesaeli N., Kaufman R.J., Michalak M. Biochem. Biophys. Res. Commun. 304:2003;661-666.
19. 2+ regulation of interactions between endoplasmic reticulum chaperones. J. Biol. Chem. 274:1999;6203-6211.
20. Knee R., Ahsan I., Mesaeli N., Kaufman R.J., Michalak M. Compromised calnexin function in calreticulin deficient cells. Biochem. Biophys. Res. Commun. 304:2003;661-666.
21. Aramburu J., Rao A., Klee C.B. Calcineurin: from structure to function. Curr. Top. Cell Regul. 36:2000;237-295.
22. Rusnak F., Mertz P. Calcineurin: form and function. Physiol. Rev. 80:2000;1483-1521.
23. Perrino B.A., Fong Y.L., Brickey D.A., Saitoh Y., Ushio Y., Fukunaga K., Miyamoto E., Soderling T.R. Characterization of the phosphatase activity of a baculovirus-expressed calcineurin A isoform. J. Biol. Chem. 267:1992;15965- 15969.
24. Milan D., Griffith J., Su M., Price E.R., McKeon F. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell. 79:1994;437-447.
25. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J. Biol. Chem. 276:2001;2313-2316.
26. 2+ flux. Cell. 83:1995;463-472.
27. Baksh S., Burakoff S.J. The role of calcineurin in lymphocyte activation. Semin. Immunol. 12:2000;405-415.
28. Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A., Tempczyk A., Kalish V.J., Tucker K.D., Showalter R.E., Moomaw E.W.et al. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 378:1995;641-644.
29. Stemmer P.M., Klee C.B. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry. 33:1994;6859-6866.
30. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
31. Frey N., Olson E.N. Making matters worse for a broken heart. J. Clin. Invest. 106:2000;1437-1439.
32. Sugden P.H. Signaling in myocardial hypertrophy: life after calcineurin? Circ. Res. 84:1999;633-646.
33. Wilkins B.J., Molkentin J.D. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J. Physiol. 541:2002;1-8.
34. Guo L., Nakamura K., Lynch J., Opas M., Olson E.N., Agellon L.B., Michalak M. Cardiac-specific expression of calcineurin reverses embryonic lethality in calreticulin-deficient mouse. J. Biol. Chem. 277:2002;50776-50779.
35. delaPompa J.L., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., Potter J., Wakeham A., Marengere L., Langille B.L., Crabtree G.R., Mak T.W. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 392:1998;182-186.
36. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 392:1998;186-190.
37. Taigen T., De Windt L.J., Lim H.W., Molkentin J.D. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA. 97:2000;1196-1201.
38. De Windt L.J., Lim H.W., Bueno O.F., Liang Q., Delling U., Braz J.C., Glascock B.J., Kimball T.F., del Monte F., Hajjar R.J., Molkentin J.D. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA. 98:2001;3322-3327.
39. Olson E.N., Williams R.S. Remodeling muscles with calcineurin. Bioessays. 22:2000;510-519.
40. Mijares A., Malecot C.O., Peineau N., Argibay J.A. In vivo and in vitro inhibition of the L-type calcium current in isolated guinea-pig cardiomyocytes by the immunosuppressive agent cyclosporin A. J. Mol. Cell. Cardiol. 29:1997;2067-2076.
41. Abbott K.L., Friday B.B., Thaloor D., Murphy T.J., Pavlath G.K. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell. 9:1998;2905-2916.
42. Goy J.J., Stauffer J.C., Deruaz J.P., Gillard D., Kaufmann U., Kuntzer T., Kappenberger L. Myopathy as possible side-effect of cyclosporin. Lancet. 1:1989;1446-1447.
43. Lo A., Alloway R.R. Strategies to reduce toxicities and improve outcomes in renal transplant recipients. Pharmacotherapy. 22:2002;316-328.
44. 2+-dependent signaling pathways in the heart: potential drug targets for cardiac disease. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2:2002;1-11.
45. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:2003;45-79.
46. 2+ checkpoint in cardiac myofibrillogenesis. J. Cell Biol. 158:2002;103-113.
47. Moore R., Hernandez D., Valantine H. Calcineurin inhibitors and post-transplant hyperlipidaemias. Drug Saf. 24:2001;755-766.
48. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl. 7:2001;S13-S21.
49. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:1997;331-340.
50. Redecker P., Cetin Y. Rodent pancreatic islet cells contain the calcium-binding proteins calcineurin and calretinin. Histochem. Cell Biol. 108:1997;133-139.
51. Doyle M.E., Egan J.M. Pharmacological agents that directly modulate insulin secretion. Pharmacol. Rev. 55:2003;105-131.
52. Tamura K. FK506: mechanism of immunosuppression and adverse-effects. J. Toxicol. Sci. 20:1995;477-479.